HEMOGENYX PHARMPLC (Germany) Market Value
| 5HU Stock | EUR 4.14 0.62 13.03% |
| Symbol | HEMOGENYX |
HEMOGENYX PHARMPLC 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HEMOGENYX PHARMPLC's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HEMOGENYX PHARMPLC.
| 12/25/2023 |
| 12/19/2024 |
If you would invest 0.00 in HEMOGENYX PHARMPLC on December 25, 2023 and sell it all today you would earn a total of 0.00 from holding HEMOGENYX PHARMPLC LS 01 or generate 0.0% return on investment in HEMOGENYX PHARMPLC over 360 days. HEMOGENYX PHARMPLC is related to or competes with SUN ART, Micron Technology, CARSALESCOM, Sunny Optical, Computer, Vishay Intertechnology, and Canon Marketing. Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and com... More
HEMOGENYX PHARMPLC Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HEMOGENYX PHARMPLC's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HEMOGENYX PHARMPLC LS 01 upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 23.32 | |||
| Information Ratio | 0.1239 | |||
| Maximum Drawdown | 2233.33 | |||
| Value At Risk | (26.32) | |||
| Potential Upside | 35.71 |
HEMOGENYX PHARMPLC Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for HEMOGENYX PHARMPLC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HEMOGENYX PHARMPLC's standard deviation. In reality, there are many statistical measures that can use HEMOGENYX PHARMPLC historical prices to predict the future HEMOGENYX PHARMPLC's volatility.| Risk Adjusted Performance | 0.1086 | |||
| Jensen Alpha | 34.21 | |||
| Total Risk Alpha | 27.18 | |||
| Sortino Ratio | 1.45 | |||
| Treynor Ratio | (1.32) |
HEMOGENYX PHARMPLC Backtested Returns
HEMOGENYX PHARMPLC is out of control given 3 months investment horizon. HEMOGENYX PHARMPLC holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13% return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 16.02% are justified by taking the suggested risk. Use HEMOGENYX PHARMPLC LS 01 Semi Deviation of 17.32, market risk adjusted performance of (1.31), and Risk Adjusted Performance of 0.1086 to evaluate company specific risk that cannot be diversified away. HEMOGENYX PHARMPLC holds a performance score of 9 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -25.61, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning HEMOGENYX PHARMPLC are expected to decrease by larger amounts. On the other hand, during market turmoil, HEMOGENYX PHARMPLC is expected to outperform it. Use HEMOGENYX PHARMPLC LS 01 downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to analyze future returns on HEMOGENYX PHARMPLC LS 01.
Auto-correlation | 0.02 |
Virtually no predictability
HEMOGENYX PHARMPLC LS 01 has virtually no predictability. Overlapping area represents the amount of predictability between HEMOGENYX PHARMPLC time series from 25th of December 2023 to 22nd of June 2024 and 22nd of June 2024 to 19th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HEMOGENYX PHARMPLC price movement. The serial correlation of 0.02 indicates that only 2.0% of current HEMOGENYX PHARMPLC price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.02 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.55 |
HEMOGENYX PHARMPLC lagged returns against current returns
Autocorrelation, which is HEMOGENYX PHARMPLC stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting HEMOGENYX PHARMPLC's stock expected returns. We can calculate the autocorrelation of HEMOGENYX PHARMPLC returns to help us make a trade decision. For example, suppose you find that HEMOGENYX PHARMPLC has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
HEMOGENYX PHARMPLC regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If HEMOGENYX PHARMPLC stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if HEMOGENYX PHARMPLC stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in HEMOGENYX PHARMPLC stock over time.
Current vs Lagged Prices |
| Timeline |
HEMOGENYX PHARMPLC Lagged Returns
When evaluating HEMOGENYX PHARMPLC's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of HEMOGENYX PHARMPLC stock have on its future price. HEMOGENYX PHARMPLC autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, HEMOGENYX PHARMPLC autocorrelation shows the relationship between HEMOGENYX PHARMPLC stock current value and its past values and can show if there is a momentum factor associated with investing in HEMOGENYX PHARMPLC LS 01.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in HEMOGENYX Stock
HEMOGENYX PHARMPLC financial ratios help investors to determine whether HEMOGENYX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HEMOGENYX with respect to the benefits of owning HEMOGENYX PHARMPLC security.